ISEE(Delisted)
IVERIC bio·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ISEE
Iveric Bio, Inc.
A biopharmaceutical company focused on developing innovative therapies to treat eye diseases
8 Sylvan Way, Parsippany, NJ 07054
--
IVERIC bio, Inc., was established on January 5, 2007 and is registered in Delaware, USA. The company is a biotechnology company dedicated to the development of novel gene therapy options for the treatment of orphan inherited retinal diseases.
Company Financials
EPS
ISEE has released its 2023 Q1 earnings. EPS was reported at -0.53, versus the expected -0.46, missing expectations. The chart below visualizes how ISEE has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
